top of page
10.png

Developing RWD Generation Roadmap to Support Drug Launch

Writer's picture: Adigens HealthAdigens Health

Problem: Navigating Immunology Challenges for Drug Launch


Launching a drug in the realm of immunology presented a significant hurdle for our client. With no prior experience in this complex field, establishing the drug as a credible and effective treatment posed a formidable challenge. The competitive landscape and skepticism among clinicians added further complexity, requiring strategic positioning to establish the drug as a reliable solution for patients with gastrointestinal conditions.


Solution: Strategic Integration of Real-World Evidence and Scientific Dissemination


To address these challenges, we devised a comprehensive roadmap focused on Real-World Data (RWD) and Real-World Evidence (RWE) generation. This strategic approach aimed to leverage the power of real-world evidence and robust scientific dissemination activities. Rigorous RWE and post-marketing studies were conducted, seamlessly bridging to new clinical trial data, thereby reinforcing the drug's efficacy and safety. Proactively, our client engaged in sharing these findings with healthcare professionals through conferences, publications, and targeted outreach to clinicians.


Execution:


1. RWD and RWE Generation Roadmap: Strategically outlined a plan for generating Real-World Evidence to fortify the drug's efficacy and safety claims.

2. Robust Scientific Dissemination: Implemented an integrated approach involving conferences, publications, and direct outreach to clinicians for effective communication of findings.


Impact: Elevated Adoption and Blockbuster Success


The strategic emphasis on real-world evidence and scientific dissemination had a profound impact. Clinicians embraced the drug as a trusted treatment option, resulting in high-level uptake by prescribers. The robust scientific evidence supporting the drug's efficacy and safety contributed to its rapid adoption within the medical community. Transforming from a promising treatment to a blockbuster drug, it not only addressed the medical needs of patients but also secured a pivotal position in the pharmaceutical market. The intentional focus on evidence-based marketing and scientific engagement played a pivotal role in elevating the drug from a potential option to a widely accepted and successful therapeutic choice.

Comments


bottom of page